The first treatment of its kind for metastatic NSCLC, Optune Lua is approved for use concurrently with PD-1/PD-L1 inhibitors or docetaxel in adult patients with metastatic NSCLC who progressed on or ...
Optune Lua is now approved for use concurrently with PD-1/PD-L1 inhibitors in adult patients with unresectable advanced/recurrent NSCLC who progressed on or after platinum-based chemotherapy Ministry ...
Optune Lua is FDA approved for use with immunotherapy or docetaxel in metastatic stage IV NSCLC post-platinum treatment. The device uses tumor treating fields to disrupt cancer cell division, offering ...
Novocure received a long-sought FDA approval for the use of its Tumor Treating Fields technology against metastatic non-small cell lung cancer—which the company described as the first treatment of its ...
Optune Lua received a CE Mark for treating metastatic NSCLC, used with immune checkpoint inhibitors or docetaxel after progression on a platinum-based regimen. The phase 3 LUNAR trial showed ...
Swiss company Beekeeper has completed a multimillion euro deal to acquire Irish voicetech start-up Lua. Formerly known as Whispr, Lua has developed a real-time interactive voice technology platform ...
Very often while developing complex systems, engineers have to greatly simplify the task of writing final user space applications. In this case it is desirable to move as far as possible from the ...
DES MOINES, Iowa — Des Moines’ Lua Brewing is receiving some national recognition, and Iowans can now vote the local taproom ...
MANILA, Philippines – Julia Lua returns to action as the marked player when the ICTSI Intercollegiate Tour resumes with Round 2 of the ladies division at Caliraya Springs Golf Club on Saturday armed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback